INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.

Medical Freedom Maps

Home » Maps » Regenerative medicine » Georgia

Regenerative medicine in Georgia

Regenerative medicine laws and requirements in Georgia. Citations, verification dates, and source links for every data point.

DimensionValueCitationSourceVerifiedConfidence
Permit Unapproved Cell Therapiespermit cell therapiesO.C.G.A. § 43-34-49(b) (HB 1275, 2026)“A physician or, following a lawful designation from such physician, a physician assistant or nurse practitioner, may perform human stem cell therapy that is not approved by the FDA”Link2026-10-09high
Require Patient Disclosure for Cell Therapiesrequire disclosureO.C.G.A. § 43-34-49(g)-(j)“A physician or his or her designee who conducts human stem cell therapy pursuant to this Code section shall obtain a signed consent form from the patient”Note: Advertising must carry the 'THIS NOTICE MUST BE PROVIDED TO YOU UNDER GEORGIA LAW' notice; consent form must state the therapy is not yet FDA-approved. HB 1275 signed May 11, 2026 as Act 453 (per legiscan/secondary trackers); bill has no effective-date section, so Georgia's default July 1, 2026 applies. Stored citation Ga. Code 31-2A-1 is unrelated (Dept. of Public Health).Link2026-10-09high
Limit Practitioner Scope for Cell TherapiesPhysicians licensed under Georgia's medical practice act or, on the physician's lawful designation, a physician assistant or nurse practitioner, within scope of practice; signed patient consent required; cells from FDA-registered or WMDA/AABB/AATB-accredited facilities.O.C.G.A. § 43-34-49(b)-(c)“A physician or, following a lawful designation from such physician, a physician assistant or nurse practitioner, may perform human stem cell therapy that is not approved by the FDA”Note: Stored 'MD/DO; institutional review' not supported: statute permits PA/NP designees and requires no institutional review (FACT/AABB-accredited institutions are exempted, § 43-34-49(k)). HB 1275 signed May 11, 2026 as Act 453 (per legiscan/secondary trackers); bill has no effective-date section, so Georgia's default July 1, 2026 applies. Stored citation Ga. Code 31-2A-1 is unrelated (Dept. of Public Health).Link2026-10-09high
Have Cell Therapy Statute ReferencesO.C.G.A. § 43-34-49 (HB 1275, 2026)O.C.G.A. § 43-34-49“Article 2 of Chapter 34 of Title 43 of the Official Code of Georgia Annotated, relating to medical practice, is amended by adding a new Code section to read as follows: "43-34-49.”Note: HB 1275 signed May 11, 2026 as Act 453 (per legiscan/secondary trackers); bill has no effective-date section, so Georgia's default July 1, 2026 applies. Stored citation Ga. Code 31-2A-1 is unrelated (Dept. of Public Health).Link2026-10-09high

View full Georgia profile (all layers) · Report an error on this page

Methodology: every value was checked in October 2026 against a specific source (statute, regulator or official list, or a named tracker page), and each links to that page with a short quote. Values no source could support are shown as “Not verified”. Verification was AI-assisted and spot-checked; laws change, so confirm with the linked source before relying on a value. How values are verified · Report an error.